Denmark· DK-28107304624
EXDENSUR
A depemokimab product containing depemokimab, registered in Denmark by Glaxosmithkline Trading Services Limited. The same ATC class is registered in 9 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Depemokimab is registered in 9 of 19 countries.
Countries holding a registration under ATC R03DX12 (depemokimab), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 5 of them publish a price we can compare per daily dose
Depemokimab · ATC R03DX12
9 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Japan
- United Kingdom
- United Statesprice
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- Depemokimab
- Manufacturer
- Glaxosmithkline Trading Services Limited
- Country
- Denmark (DK)
- ATC code
- R03DX12
- ATC class
- Depemokimab
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28107304624
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under R03DX12
Depemokimab, as other registers publish it.
- United StatesExdensurGlaxoSmithKline LLC
- DenmarkEXDENSURGlaxosmithkline Trading Services Limited
- FinlandEXDENSURGlaxoSmithKline Trading Services Limited
- FinlandEXDENSURGlaxoSmithKline Trading Services Limited
- CzechiaEXDENSURGlaxoSmithKline Trading Services Limited, Dublin
- IcelandEXDENSURGlaxoSmithKline Trading Services Limited
- CzechiaEXDENSURGlaxoSmithKline Trading Services Limited, Dublin
- IcelandEXDENSURGlaxoSmithKline Trading Services Limited
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/119c9042-4b33-4da6-9f34-25c583a9db8a GET /v1/drugs/119c9042-4b33-4da6-9f34-25c583a9db8a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "injektionsvæske, opløsning i fyldt pen",
"source": "dkma",
"strength": "100 mg",
"auth_role": "MOD",
"dk_drugid": "28107304624",
"substance": "Depemokimab",
"auth_procedure": "Central",
"in_medicinpriser": true,
"registration_date_serial": "46065"
}See everything about depemokimab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.